Search

Pulmatrix Inc

Open

1.56 1.96

Overview

Share price change

24h

Current

Min

1.51

Max

1.6099999999999999

Key metrics

By Trading Economics

Income

136K

-1M

EPS

-0.29

Employees

2

EBITDA

126K

-1M

Market Stats

By TradingEconomics

Market Cap

402K

6.1M

Previous open

-0.4

Previous close

1.56

Pulmatrix Inc Chart

Past performance is not a reliable indicator of future results.

Related News

28 Sept 2026, 23:56 UTC

Scotts Miracle-Gro Co is down in after-market hours, marking a fifth consecutive session of lower performance and remaining below its 20-day moving average.

28 Sept 2026, 23:56 UTC

Correlated Moves

BILL Holdings Inc trades modestly higher in after-market hours, supported by positive momentum in Gen Digital Inc following optimistic comments on its fiscal 2027 outlook.

28 Sept 2026, 23:56 UTC

Correlated Moves

Pinnacle West Capital Corp traded modestly higher in after-market hours, maintaining a steady return since Monday's close, despite broader market conditions.

28 Sept 2026, 23:56 UTC

Patterson-UTI Energy Inc is gaining modestly in after-market trading, continuing a routine move since Monday's close while remaining below its 20-day moving average.

28 Sept 2026, 23:55 UTC

Gray Media Inc has advanced modestly in after-market trading, reflecting a shift in momentum despite remaining below its 20-day moving average.

28 Sept 2026, 23:55 UTC

Voya Financial Inc is trading lower in after-market hours, remaining near the low end of its one-month range and below its 20-day moving average.

28 Sept 2026, 23:55 UTC

Global Net Lease Inc is trading modestly higher in after-market hours, reflecting stronger performance compared to the previous seven sessions that all ended lower.

28 Sept 2026, 23:55 UTC

News

Neurocrine Biosciences shares rise in after-market trading following the return of Eiry W. Roberts, M.D., as Chief Medical Officer, ensuring continuity for late-stage programs.

28 Sept 2026, 23:55 UTC

Emerson Electric Co is trading modestly higher in after-market hours, significantly above its 20-day moving average and showing notable upward movement since Monday's close.

28 Sept 2026, 23:55 UTC

Huntington Bancshares Inc is trading modestly higher in after-market hours, stabilizing above earlier session lows while remaining below its 20-day moving average.

28 Sept 2026, 23:55 UTC

F5 Inc's shares are trading modestly lower in after-market hours, continuing a downward trend that has persisted for five consecutive sessions.

28 Sept 2026, 23:55 UTC

Xenon Pharmaceuticals Inc. is trading lower in after-hours, shifting from a slight gain to a more substantial loss since Monday's close, remaining below its 20-day moving average.

28 Sept 2026, 23:55 UTC

CMS Energy Corp is trading modestly higher in after-market hours, recovering from a low point immediately after the regular session close.

28 Sept 2026, 23:55 UTC

APA Corp's shares advanced modestly in after-market trading, stabilizing after earlier gains but remaining below the 20-day moving average.

28 Sept 2026, 23:51 UTC

Novavax Inc. traded modestly higher during after-market hours, remaining above its 20-day moving average and near the upper end of its one-month range.

28 Sept 2026, 23:51 UTC

Leonardo DRS Inc is trading modestly higher in after-market hours, rebounding from an earlier session low and showing unusual strength compared to typical patterns.

28 Sept 2026, 23:51 UTC

News

ACADIA Pharmaceuticals shares declined in after-market hours despite the allowance of a U.S. patent for weight-banded dosing of trofinetide, extending protections until March 2041.

28 Sept 2026, 23:51 UTC

In after-market trading, MercadoLibre Inc is rising following four sessions of decline, amid significant gains in the Broadline Retail sub-sector.

28 Sept 2026, 23:51 UTC

Peloton Interactive Inc is declining in after-market trading, hitting its lowest point of the day and remaining below its 20-day moving average.

28 Sept 2026, 23:51 UTC

EHang Holdings Ltd is rising in after-market trading, gaining ground after five consecutive lower sessions, despite remaining below its 20-day moving average.

28 Sept 2026, 23:51 UTC

CF Industries Holdings Inc saw a modest decline in after-market trading, remaining near the lower end of its one-month range and below its 20-day moving average.

28 Sept 2026, 23:51 UTC

Affiliated Managers Group Inc is trading lower in after-market hours, continuing a decline since Monday's close despite earlier gains during the session.

28 Sept 2026, 23:51 UTC

Qfin Holdings Inc saw a notable rise in after-market trading, advancing sharply following eight consecutive lower daily finishes, though still below its 20-day moving average.

28 Sept 2026, 23:51 UTC

News

Prospect Capital Corp shares are trading higher in after-market hours following a cash distribution announcement of $0.56232 per share from its fund.

28 Sept 2026, 23:51 UTC

Block Inc declined in after-market hours, continuing a trend of lower closes amid broader market weakness and trading significantly below its 20-day moving average.

28 Sept 2026, 23:51 UTC

Australia's Balance of Trade report on October 1 is expected to show a AUD 2.1 billion surplus, reflecting strong resource exports amid cautious market optimism and global inflation concerns.

28 Sept 2026, 23:51 UTC

JOLTs Job Openings Data Release on September 29 Expected to Show Decline Amid Rising Inflation Fears and Geopolitical Tensions, Influencing Fed Rate Hike Speculations.

28 Sept 2026, 23:51 UTC

US Initial Jobless Claims Expected at 200K, Indicating Labor Market Resilience Amid Inflation Concerns

28 Sept 2026, 23:51 UTC

News

Boston Scientific Corp. has secured a contract worth up to $135.7 million from the U.S. Department of Defense, while shares have moved modestly lower in after-market trading.

28 Sept 2026, 23:51 UTC

Molson Coors Beverage Co's shares traded modestly higher in after-market hours on Monday, despite fluctuations and positioning below the 20-day moving average.

Peer Comparison

Price change

Pulmatrix Inc Forecast

Rating Consensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Pulmatrix Inc

Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts.